- |||||||||| carboplatin / Generic mfg., paclitaxel / Generic mfg., sorafenib / Generic mfg.
Enrollment change, Trial withdrawal, Combination therapy: Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer (clinicaltrials.gov) - Jan 10, 2019 P1/2, N=0, Withdrawn, N=84 --> 0 | Terminated --> Withdrawn
- |||||||||| erlotinib / Generic mfg.
Trial completion, Trial primary completion date, Metastases: Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer (clinicaltrials.gov) - Jun 8, 2017 P2, N=116, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Dec 2012 --> Sep 2011
- |||||||||| Avastin (bevacizumab) / Roche
Trial completion, Metastases: Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel (clinicaltrials.gov) - May 19, 2017 P=N/A, N=180, Completed, Active, not recruiting --> Completed Not yet recruiting --> Completed
- |||||||||| Tavocept (dimesna) / BioNumerik, Lantern Pharma, Aranesp (darbepoetin alfa) / Amgen, Kyowa Kirin, Neulasta (pegfilgrastim) / Amgen, Kyowa Kirin, Roche
Trial completion, Metastases: Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (clinicaltrials.gov) - Jun 28, 2016 P2, N=160, Completed, No longer recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Erbitux (cetuximab) / Eli Lilly, EMD Serono
Trial completion, Combination therapy: Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer (clinicaltrials.gov) - Nov 16, 2015 P2, N=0, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| cixutumumab (IMC A12) / Eli Lilly, Avastin (bevacizumab) / Roche
Trial primary completion date, Metastases: Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (clinicaltrials.gov) - Sep 21, 2015 P2, N=180, Active, not recruiting, Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Aug 2015 Trial primary completion date: Sep 2015 --> Dec 2015
- |||||||||| erlotinib / Generic mfg.
Trial completion, Trial primary completion date, Metastases: Therapeutic Strategy in Advanced Bronchioloalveolar Carcinoma (clinicaltrials.gov) - Feb 19, 2015 P2, N=133, Completed, Recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Jul 2012 --> Feb 2014
- |||||||||| selenomethionine (SLM) / University of Iowa, Holden Comprehensive Cancer Center
Enrollment change, Combination therapy, Surgery: Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery (clinicaltrials.gov) - Jan 15, 2015 P2, N=16, Terminated, Active, not recruiting --> Completed | Trial primary completion date: Jul 2012 --> Feb 2014 N=30 --> 16
- |||||||||| Avastin (bevacizumab) / Roche
Enrollment closed, Trial primary completion date: Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers (clinicaltrials.gov) - Dec 10, 2014 P2, N=40, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2014 --> Nov 2015
- |||||||||| carboplatin / Generic mfg., paclitaxel / Generic mfg., gefitinib / Generic mfg.
Trial completion: Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer (clinicaltrials.gov) - Feb 22, 2014 P2, N=144, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Neulasta (pegfilgrastim) / Amgen, Kyowa Kirin, Roche
Trial completion, Metastases: Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (clinicaltrials.gov) - Nov 12, 2013 P2, N=45, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| cixutumumab (IMC A12) / Eli Lilly, Avastin (bevacizumab) / Roche
Enrollment closed, Metastases: Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (clinicaltrials.gov) - Oct 6, 2013 P2, N=180, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- |||||||||| carboplatin / Generic mfg., paclitaxel / Generic mfg., gemcitabine / Generic mfg.
Trial withdrawal, Combination therapy, Metastases: Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer (clinicaltrials.gov) - Jul 9, 2013 P3, N=0, Withdrawn, Recruiting --> Active, not recruiting Active, not recruiting --> Withdrawn
|